Warburg-Mubadala in the lead to acquire Indian pharma Encube Ethicals at USD 1.8 bn valuation
Topical Indian drug maker Encube Ethicals emerges as a beneficiary as US moves away from China’s pharma supply chain
Available in your choice of English or Arabic
Topical Indian drug maker Encube Ethicals emerges as a beneficiary as US moves away from China’s pharma supply chain
The Dubai-based lender is competing with Canada’s Fairfax for 60.7% of IDBI
The two parties inked a terms of reference to launch negotiations for a trade agreement
Markets rallied after US President Trump announced a tariff cut for Indian exports in exchange for an end to Russian…
India’s Budget for FY 2027 expands incentives on manufacturing and infra but the state-led growth strategy still lacks a credible…
Despite steep US tariffs and geopolitical headwinds, India’s domestic growth engines are expected drive the fast-paced growth
The pact delivers sweeping tariff cuts on goods and services, with India securing near-universal access for labor-intensive exports
DP World is extending its India footprint beyond ports into the country’s industrial hinterland, building a rail-linked logistics hub in…
Something went wrong. Please refresh the page and/or try again.
Queue